HighTower Advisors
OSTX

HighTower Advisors’s OS Therapies Inc OSTX Stock Holding History

HighTower Advisors’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
85,550
+70,350
+463% +$118K ﹤0.01% 3581
2026
Q1 		$21.4K Buy
+15,200
New +$21.6K ﹤0.01% 3755

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

HighTower Advisors's OSTX Position: Q2 2026 in Review

HighTower Advisors increased its OS Therapies Inc (OSTX) stake by 463% in Q2 2026, buying an estimated $118K and bringing the position to 85,550 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3581.

HighTower Advisors first reported a position in OSTX in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • HighTower Advisors held 85,550 shares of OS Therapies Inc worth $163K as of Q2 2026.
  • HighTower Advisors bought 70,350 OS Therapies Inc shares in Q2 2026, an estimated $118K.
  • OS Therapies Inc made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3581 holding.
  • HighTower Advisors first reported a position in OS Therapies Inc in Q1 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.